CA2058632A1 - Exonuclease-resistant oligonucleotides and methods for preparing the same - Google Patents
Exonuclease-resistant oligonucleotides and methods for preparing the sameInfo
- Publication number
- CA2058632A1 CA2058632A1 CA002058632A CA2058632A CA2058632A1 CA 2058632 A1 CA2058632 A1 CA 2058632A1 CA 002058632 A CA002058632 A CA 002058632A CA 2058632 A CA2058632 A CA 2058632A CA 2058632 A1 CA2058632 A1 CA 2058632A1
- Authority
- CA
- Canada
- Prior art keywords
- exonuclease
- preparing
- methods
- same
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091034117 Oligonucleotide Proteins 0.000 title abstract 6
- 108060002716 Exonuclease Proteins 0.000 title abstract 3
- 102000013165 exonuclease Human genes 0.000 title abstract 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000015556 catabolic process Effects 0.000 abstract 2
- 238000006731 degradation reaction Methods 0.000 abstract 2
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 abstract 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical compound OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method is provided for making 3' and/or 5' end-capped oligonucleotides so as to render the oligonucleotide resistant to degradation by exonucleases. The exonuclease degradation resistance is provided by incorporating two or more phosphoramidate and phosphoromonothioate and/or phosphorodithioate linkages at the 5' and/or 3' ends of the oligonucleotide, wherein the number of phosphoramidate linkages is less than a number which would interfere with hybridization to a complementary oligon-ucleotide strand and/or which would interfere with RNAseH activity when the oligonucleotide is hybridized to RNA.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36104589A | 1989-06-05 | 1989-06-05 | |
US361,045 | 1989-06-05 | ||
PCT/US1990/003138 WO1990015065A1 (en) | 1989-06-05 | 1990-06-05 | Exonuclease-resistant oligonucleotides and methods for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2058632A1 true CA2058632A1 (en) | 1990-12-06 |
CA2058632C CA2058632C (en) | 2004-08-24 |
Family
ID=23420432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002058632A Expired - Lifetime CA2058632C (en) | 1989-06-05 | 1990-06-05 | Exonuclease-resistant oligonucleotides and methods for preparing the same |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0476071A4 (en) |
JP (1) | JPH05500799A (en) |
KR (1) | KR920701230A (en) |
CA (1) | CA2058632C (en) |
WO (1) | WO1990015065A1 (en) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5149797A (en) * | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
US5220007A (en) * | 1990-02-15 | 1993-06-15 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of RNA and production of encoded polypeptides |
WO1994008003A1 (en) * | 1991-06-14 | 1994-04-14 | Isis Pharmaceuticals, Inc. | ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE |
US5965722A (en) | 1991-05-21 | 1999-10-12 | Isis Pharmaceuticals, Inc. | Antisense inhibition of ras gene with chimeric and alternating oligonucleotides |
US5792608A (en) * | 1991-12-12 | 1998-08-11 | Gilead Sciences, Inc. | Nuclease stable and binding competent oligomers and methods for their use |
AU3250093A (en) | 1991-12-12 | 1993-07-19 | Gilead Sciences, Inc. | Nuclease stable and binding competent oligomers and methods for their use |
US5434257A (en) * | 1992-06-01 | 1995-07-18 | Gilead Sciences, Inc. | Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages |
RU95104940A (en) * | 1992-07-27 | 1997-01-10 | Хайбрайдон | Method of incorporation of alkylphosphonothioate or arylphosphonothioate internucleotide linkage in oligonucleotide, method of oligonucleotide synthesis, method of gene expression inhibition, treatment method |
US5719273A (en) * | 1993-06-14 | 1998-02-17 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide |
US5580972A (en) * | 1993-06-14 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | Purine nucleoside modifications by palladium catalyzed methods |
JPH09510351A (en) * | 1994-03-16 | 1997-10-21 | ジェン−プローブ・インコーポレイテッド | Isothermal strand displacement nucleic acid amplification method |
US6111095A (en) * | 1995-06-07 | 2000-08-29 | Merck & Co., Inc. | Capped synthetic RNA, analogs, and aptamers |
EP0830368A1 (en) | 1995-06-07 | 1998-03-25 | Genta Incorporated | Novel carbamate-based cationic lipids |
CA2250923A1 (en) * | 1996-03-26 | 1997-10-02 | Gabriella Zupi | Oligonucleotide treatments and compositions for human melanoma |
US5959100A (en) | 1996-03-27 | 1999-09-28 | Nexstar Pharmaceuticals, Inc. | Pyrimidine nucleosides as therapeutic and diagnostic agents |
US5945527A (en) * | 1996-05-30 | 1999-08-31 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
US6576752B1 (en) | 1997-02-14 | 2003-06-10 | Isis Pharmaceuticals, Inc. | Aminooxy functionalized oligomers |
US6172209B1 (en) | 1997-02-14 | 2001-01-09 | Isis Pharmaceuticals Inc. | Aminooxy-modified oligonucleotides and methods for making same |
US6127533A (en) | 1997-02-14 | 2000-10-03 | Isis Pharmaceuticals, Inc. | 2'-O-aminooxy-modified oligonucleotides |
US6007992A (en) * | 1997-11-10 | 1999-12-28 | Gilead Sciences, Inc. | Pyrimidine derivatives for labeled binding partners |
US6028183A (en) | 1997-11-07 | 2000-02-22 | Gilead Sciences, Inc. | Pyrimidine derivatives and oligonucleotides containing same |
US6673912B1 (en) | 1998-08-07 | 2004-01-06 | Isis Pharmaceuticals, Inc. | 2′-O-aminoethyloxyethyl-modified oligonucleotides |
US6043352A (en) | 1998-08-07 | 2000-03-28 | Isis Pharmaceuticals, Inc. | 2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides |
US6020483A (en) | 1998-09-25 | 2000-02-01 | Nexstar Pharmaceuticals, Inc. | Nucleoside modifications by palladium catalyzed methods |
US6207819B1 (en) * | 1999-02-12 | 2001-03-27 | Isis Pharmaceuticals, Inc. | Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds |
AU2001262108A1 (en) * | 2000-03-17 | 2001-09-24 | Unilever Plc | Non-physiologic dna fragments for tanning skin |
KR100865706B1 (en) * | 2000-09-26 | 2008-10-28 | 이데라 파마슈티칼즈, 인코포레이티드 | Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
US6989452B2 (en) | 2001-05-31 | 2006-01-24 | Medarex, Inc. | Disulfide prodrugs and linkers and stabilizers useful therefor |
US7255874B1 (en) | 2001-12-21 | 2007-08-14 | Closure Medical Corporation | Biocompatible polymers and adhesives: compositions, methods of making and uses related thereto |
US7125945B2 (en) | 2003-09-19 | 2006-10-24 | Varian, Inc. | Functionalized polymer for oligonucleotide purification |
US20080279868A1 (en) | 2005-09-26 | 2008-11-13 | Medarex, Inc. | Antibody-Drug Conjugates and Methods of Use |
US7947447B2 (en) | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
US8583380B2 (en) | 2008-09-05 | 2013-11-12 | Aueon, Inc. | Methods for stratifying and annotating cancer drug treatment options |
SG184497A1 (en) | 2010-04-12 | 2012-11-29 | Somalogic Inc | 5-position modified pyrimidines and their use |
AU2014353102B2 (en) | 2013-11-21 | 2019-05-16 | Somalogic Operating Co., Inc. | Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto |
EP3169781B1 (en) * | 2014-07-15 | 2020-04-08 | Life Technologies Corporation | Compositions and methods for nucleic acid assembly |
RS62434B1 (en) | 2014-12-26 | 2021-11-30 | Univ Emory | Anti-viral n4-hydroxycytidine derivatives |
KR102626210B1 (en) | 2017-12-07 | 2024-01-18 | 에모리 유니버시티 | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
WO2024114305A1 (en) * | 2022-11-29 | 2024-06-06 | Vacino Biotech Co., Ltd. | Oligonucleotide therapeutics and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4415732A (en) * | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
US4849513A (en) * | 1983-12-20 | 1989-07-18 | California Institute Of Technology | Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups |
WO1986007362A1 (en) * | 1985-06-14 | 1986-12-18 | University Patents, Inc. | Method for synthesizing deoxyoligonucleotides |
ATE151467T1 (en) * | 1987-11-30 | 1997-04-15 | Univ Iowa Res Found | DNA MOLECULES STABILIZED BY MODIFICATIONS TO THE 3'-TERMINAL PHOSPHODIESTER BOND, THEIR USE AS NUCLEIC ACID PROBE AND AS THERAPEUTIC AGENTS FOR INHIBITING THE EXPRESSION OF SPECIFIC TARGET GENES |
-
1990
- 1990-06-05 WO PCT/US1990/003138 patent/WO1990015065A1/en not_active Application Discontinuation
- 1990-06-05 CA CA002058632A patent/CA2058632C/en not_active Expired - Lifetime
- 1990-06-05 KR KR1019910701767A patent/KR920701230A/en not_active Application Discontinuation
- 1990-06-05 JP JP2509531A patent/JPH05500799A/en active Pending
- 1990-06-05 EP EP19900913804 patent/EP0476071A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0476071A1 (en) | 1992-03-25 |
KR920701230A (en) | 1992-08-11 |
EP0476071A4 (en) | 1992-11-04 |
WO1990015065A1 (en) | 1990-12-13 |
CA2058632C (en) | 2004-08-24 |
JPH05500799A (en) | 1993-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2058632A1 (en) | Exonuclease-resistant oligonucleotides and methods for preparing the same | |
CA2095624A1 (en) | Method of targeting dna | |
WO1994009129A3 (en) | Method of cleaving specific strands of rna | |
EP0251283A3 (en) | Poly-labelled oligonucleotide derivative | |
CA2184375A1 (en) | Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties | |
CA2160016A1 (en) | Method of forming oligonucleotides | |
WO1991006626A3 (en) | Triple helix formation in oligonucleotide therapy | |
CA2153898A1 (en) | Method for generating single-stranded dna molecules | |
IL97804A0 (en) | Oligonucleotide analogs | |
WO1999009154A3 (en) | Novel hiv-specific synthetic oligonucleotides and methods of their use | |
EP1889911A3 (en) | An antisense oligonucleotide preparation method | |
DE69615411D1 (en) | Process for the preparation of polynucleotides with desired properties by means of repeated selection and recombination | |
CA2230791A1 (en) | Hydrophilic plant growth substrate comprising a furan resin | |
CA2037349A1 (en) | Branch migration of nucleotides | |
FR2569421B1 (en) | PLASMID AND DNA FRAGMENT COMPRISING A GENE FOR TETRACYCLINE RESISTANCE, MICROORGANISM CULTURE CONTAINING THE ABOVE PLASMIDE, AND MICROORGANISM CONTAINING SAID DNA FRAGMENT | |
HU9303023D0 (en) | Peptide nucleicadis and method for producing them | |
CA2045891A1 (en) | Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages | |
CA2162361A1 (en) | Antisense oligonucleotides which combat aberrant splicing and methods of using the same | |
DE3575731D1 (en) | LARGE PRODUCTION OF DNA. | |
EP1329519A3 (en) | Probe for diagnosing infectious disease arising from Staphylococcus aureus | |
CA2048330A1 (en) | Hydrotreating Catalyst: Composition, Preparation, and Use Thereof | |
DE69521517D1 (en) | PRODRUG OLIGONUCLEOTIDES | |
CA2146658A1 (en) | Dna compounds comprising sequences encoding mannuronan c-5-epimerase | |
ES2015665A6 (en) | Nucleoside and polynucleotide thiophosphoramidite and phosphorodithioate compounds and processes. | |
EP0986006A3 (en) | A group object in a control system, and a control system using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |